We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Blood Test Could Predict Kidney Disease Trajectories

By LabMedica International staff writers
Posted on 23 Jul 2025

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited condition that can lead to kidney failure. More...

Accurately predicting how the disease will progress is critical for selecting appropriate treatments and providing informed patient counselling. However, current prediction tools are often inadequate, relying on MRI scans or genetic testing, which are not always accessible. As a result, there is a need for more effective, widely applicable methods to determine disease progression. In a new study, researchers have discovered that specific proteins in the blood can indicate how rapidly kidney function is likely to decline, offering a promising testing alternative to existing methods.

In the study, researchers from the University of Cologne (Cologne, Germany) used mass spectrometry to analyze blood samples from one of the world’s largest and best-characterized ADPKD patient cohorts. They integrated a novel robotic pipeline to process more than 1,000 samples and generate a serum proteomics-based prediction model. This approach enabled them to identify 29 proteins involved in immune function, fat transport, and metabolism that are strongly associated with the rate of kidney function decline. The collaborative research also reflects joint efforts between clinician scientists and computational biologists to bridge laboratory discovery and clinical application.

Their findings, published in Nature Communications, confirm that blood proteins can serve as biomarkers for ADPKD progression and reveal underlying mechanisms of the disease. The study shows that proteomics not only improves prediction but also provides insights into biological processes that drive ADPKD. These biomarkers may help personalize care by identifying patients at higher risk and guiding treatment decisions earlier. The researchers now plan to explore how current therapies influence proteome patterns and to develop new proteome-based markers for routine clinical use.

"Our study shows that blood proteins can offer powerful clues about how fast a patient's kidney function is likely to decline, potentially allowing for more personalized care in the most common genetic cause of kidney failure, ADPKD," said Professor Dr. Roman-Ulrich Müller, principal investigator. “By identifying specific proteins linked to disease progression, we’ve taken a meaningful step towards more accurate and earlier prediction, beyond what current clinical tools can provide.”


New
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
Clinical Chemistry System
P780
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.